CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
Authors
Hinda Boutrid
Colleen Cebulla
+9 more
Magda Celdran
William Feuer
Samuel K Houston
Ted J Lampidis
Jaime Merchan
Timothy G Murray
Yolanda Piña
Amy C Schefler
Wei Shi
Publication date
1 January 2011
Publisher
Dove Medical Press
Doi
Cite
View
on
PubMed
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Sustaining member
University of Miami: Scholarship@Miami
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:alma.01UOML_INST:113771106...
Last time updated on 16/01/2024
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.2147%2Fopth.s15179
Last time updated on 01/04/2019